Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, California 95817.
Department of Neurology.
J Neurosci. 2018 Feb 14;38(7):1802-1820. doi: 10.1523/JNEUROSCI.1291-17.2018. Epub 2018 Jan 15.
In the CNS, myelination and remyelination depend on the successful progression and maturation of oligodendroglial lineage cells, including proliferation and differentiation of oligodendroglial progenitor cells (OPCs). Previous studies have reported that Sox2 transiently regulates oligodendrocyte (OL) differentiation in the embryonic and perinatal spinal cord and appears dispensable for myelination in the postnatal spinal cord. However, the role of Sox2 in OL development in the brain has yet to be defined. We now report that Sox2 is an essential positive regulator of developmental myelination in the postnatal murine brain of both sexes. Stage-specific paradigms of genetic disruption demonstrated that Sox2 regulated brain myelination by coordinating upstream OPC population supply and downstream OL differentiation. Transcriptomic analyses further supported a crucial role of Sox2 in brain developmental myelination. Consistently, oligodendroglial Sox2-deficient mice developed severe tremors and ataxia, typical phenotypes indicative of hypomyelination, and displayed severe impairment of motor function and prominent deficits of brain OL differentiation and myelination persisting into the later CNS developmental stages. We also found that Sox2 was required for efficient OPC proliferation and expansion and OL regeneration during remyelination in the adult brain and spinal cord. Together, our genetic evidence reveals an essential role of Sox2 in brain myelination and CNS remyelination, and suggests that manipulation of Sox2 and/or Sox2-mediated downstream pathways may be therapeutic in promoting CNS myelin repair. Promoting myelin formation and repair has translational significance in treating myelin-related neurological disorders, such as periventricular leukomalacia and multiple sclerosis in which brain developmental myelin formation and myelin repair are severely affected, respectively. In this report, analyses of a series of genetic conditional knock-out systems targeting different oligodendrocyte stages reveal a previously unappreciated role of Sox2 in coordinating upstream proliferation and downstream differentiation of oligodendroglial lineage cells in the mouse brain during developmental myelination and CNS remyelination. Our study points to the potential of manipulating Sox2 and its downstream pathways to promote oligodendrocyte regeneration and CNS myelin repair.
在中枢神经系统中,少突胶质细胞的髓鞘形成和再髓鞘依赖于少突胶质细胞谱系细胞的成功增殖和成熟,包括少突胶质前体细胞(OPC)的增殖和分化。先前的研究报道,Sox2 短暂调节胚胎和围产期脊髓中的少突胶质细胞(OL)分化,并且在出生后脊髓中的髓鞘形成中似乎是可有可无的。然而,Sox2 在大脑中 OL 发育中的作用尚未确定。我们现在报告 Sox2 是两性出生后鼠脑发育性髓鞘形成的必需的正调控因子。阶段特异性遗传破坏范式表明,Sox2 通过协调上游 OPC 群体供应和下游 OL 分化来调节脑髓鞘形成。转录组分析进一步支持 Sox2 在脑发育性髓鞘形成中的关键作用。一致地,少突胶质 Sox2 缺陷型小鼠表现出严重的震颤和共济失调,这是低髓鞘形成的典型表型,并且表现出严重的运动功能障碍以及大脑 OL 分化和髓鞘形成的明显缺陷,持续到中枢神经系统发育的后期阶段。我们还发现 Sox2 对于成年大脑和脊髓中的再髓鞘过程中 OPC 的增殖和扩增以及 OL 的再生是必需的。总的来说,我们的遗传证据揭示了 Sox2 在脑髓鞘形成和中枢神经系统再髓鞘中的重要作用,并表明 Sox2 和/或 Sox2 介导的下游途径的操纵可能在促进中枢神经系统髓鞘修复方面具有治疗作用。促进髓鞘形成和修复在治疗髓鞘相关神经疾病方面具有转化意义,例如脑室周围白质软化症和多发性硬化症,其中大脑发育性髓鞘形成和髓鞘修复受到严重影响。在本报告中,对靶向不同少突胶质细胞阶段的一系列遗传条件性敲除系统的分析揭示了 Sox2 在协调发育性髓鞘形成和中枢神经系统再髓鞘过程中大脑中少突胶质细胞谱系细胞的上游增殖和下游分化中的以前未被认识到的作用。我们的研究指出了操纵 Sox2 及其下游途径以促进少突胶质细胞再生和中枢神经系统髓鞘修复的潜力。